Tilray Brands (TLRY) Return on Capital Employed (2018 - 2026)
Tilray Brands' (TLRY) quarterly Return on Capital Employed came in at 3.42% in Q2 2026, up 95.8% on a QoQ basis from 81.49% in Q1 2026.
Tilray Brands (TLRY) Return on Capital Employed (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Return on Capital Employed data on file, last reported at 3.42% in Q2 2026.
- Quarterly Return on Capital Employed changed N/A year-over-year to 3.42% in Q2 2026, while the trailing twelve-month figure through May 2026 was 3.42% (changed N/A YoY) and the FY2026 annual result came in at 3.42%, up 7232.0% from the prior year.
- Return on Capital Employed grew to 3.42% in Q2 2026, from 81.49% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3.42% in Q2 2026 to a low of 123.92% in Q3 2025.
- A 5-year average of 33.25% and a median of 11.17% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 3292 bps — and 2025, when it slumped 11944 bps.
- Tracing TLRY's Return on Capital Employed over 5 years: stood at 10.94% in 2022, then sank by 216 bps to 34.57% in 2023, then jumped by 87 bps to 4.49% in 2024, then plunged by 2603 bps to 121.45% in 2025, then jumped by 97 bps to 3.42% in 2026.
- The last three Return on Capital Employed figures came in at 3.42% (Q2 2026), 81.49% (Q1 2026), and 121.45% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 513.31 Mn | 278.68 Mn | 90.52 Mn | -3.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -3.42% |
| Feb 28, 2026 | -81.49% |
| Nov 30, 2025 | -121.45% |
| Aug 31, 2025 | -123.92% |
| Nov 30, 2024 | -4.49% |
| Aug 31, 2024 | -4.48% |
| May 31, 2024 | -4.46% |
| Feb 29, 2024 | -6.30% |
| Nov 30, 2023 | -34.57% |
| Aug 31, 2023 | -36.22% |
| May 31, 2023 | -35.04% |
| Feb 28, 2023 | -39.21% |
| Nov 30, 2022 | -10.94% |
| Aug 31, 2022 | -10.71% |
| May 31, 2022 | -11.40% |
| Feb 28, 2022 | -3.93% |
| Nov 30, 2021 | -4.00% |
| Aug 31, 2021 | -3.52% |
| May 31, 2020 | -23.44% |
| Mar 31, 2020 | -41.96% |